G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 2.78 INR -3.47% Market Closed
Market Cap: 1.5B INR
Have any thoughts about
Genpharmasec Ltd?
Write Note
GENPHARMA
/
Balance Sheet
/
Note Receivable

Genpharmasec Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genpharmasec Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
G
Genpharmasec Ltd
BSE:531592
Note Receivable
₹112.5m
CAGR 3-Years
138%
CAGR 5-Years
33%
CAGR 10-Years
N/A
S
Shree Global Tradefin Ltd
BSE:512463
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
A-1 Acid Ltd
BSE:542012
Note Receivable
-₹18m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Adani Enterprises Ltd
NSE:ADANIENT
Note Receivable
₹67.4B
CAGR 3-Years
13%
CAGR 5-Years
31%
CAGR 10-Years
3%
Refex Industries Ltd
NSE:REFEX
Note Receivable
₹3.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indiamart Intermesh Ltd
NSE:INDIAMART
Note Receivable
₹167.4m
CAGR 3-Years
-12%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Genpharmasec Ltd
Glance View

Market Cap
1.5B INR
Industry
Trading Companies & Distributors

Genpharmasec Ltd. engages in manufacturing and trading in Organic and Inorganic Chemicals, Dyes and Pigments Its products include potassium hydroxide and caustic soda. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of diagnostic equipment, pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, herbs, and in pharmaceutical, medicinal, and proprietary and industrial preparations, compounds and articles of kinds, chemists, druggists, and chemical manufacturers.

GENPHARMA Intrinsic Value
0.92 INR
Overvaluation 67%
Intrinsic Value
Price
G
What is Intrinsic Value?

See Also

What is Genpharmasec Ltd's Note Receivable?
Note Receivable
112.5m INR

Based on the financial report for Jun 30, 2024, Genpharmasec Ltd's Note Receivable amounts to 112.5m INR.

What is Genpharmasec Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
33%

The average annual Note Receivable growth rates for Genpharmasec Ltd have been 138% over the past three years , 33% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 200,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.